Meghan Shea

1.3k total citations
32 papers, 777 citations indexed

About

Meghan Shea is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Meghan Shea has authored 32 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Meghan Shea's work include Lung Cancer Research Studies (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Advanced Breast Cancer Therapies (6 papers). Meghan Shea is often cited by papers focused on Lung Cancer Research Studies (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Advanced Breast Cancer Therapies (6 papers). Meghan Shea collaborates with scholars based in United States, Israel and United Kingdom. Meghan Shea's co-authors include Daniel B. Costa, Deepa Rangachari, Paul A. VanderLaan, Mark S. Huberman, Kartik Sehgal, Xiuning Le, Susumu Kobayashi, Michele R. Hacker, Katharine M. Esselen and Sara Bouberhan and has published in prestigious journals such as Journal of Clinical Oncology, The FASEB Journal and Annals of Oncology.

In The Last Decade

Meghan Shea

24 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meghan Shea United States 13 449 373 148 125 97 32 777
Rosa Giuliani Italy 15 524 1.2× 128 0.3× 105 0.7× 166 1.3× 66 0.7× 31 805
Gül Başaran Türkiye 13 605 1.3× 249 0.7× 55 0.4× 143 1.1× 107 1.1× 50 952
F Marchesi Italy 3 446 1.0× 214 0.6× 54 0.4× 70 0.6× 126 1.3× 3 778
Chongqing Tan China 18 632 1.4× 541 1.5× 241 1.6× 96 0.8× 91 0.9× 65 978
G. Schubert-Fritschle Germany 16 485 1.1× 217 0.6× 33 0.2× 164 1.3× 133 1.4× 58 847
Atara Ntekim Nigeria 12 198 0.4× 129 0.3× 36 0.2× 152 1.2× 69 0.7× 48 536
Daniele Lisi Italy 7 559 1.2× 303 0.8× 56 0.4× 110 0.9× 181 1.9× 10 1.0k
Laura Marandino Italy 19 477 1.1× 360 1.0× 69 0.5× 227 1.8× 71 0.7× 95 1.1k
Bernardo H. L. Goulart United States 14 415 0.9× 439 1.2× 93 0.6× 100 0.8× 35 0.4× 51 848
Mihaela Mates Canada 15 572 1.3× 188 0.5× 58 0.4× 99 0.8× 69 0.7× 50 837

Countries citing papers authored by Meghan Shea

Since Specialization
Citations

This map shows the geographic impact of Meghan Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan Shea more than expected).

Fields of papers citing papers by Meghan Shea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan Shea. The network helps show where Meghan Shea may publish in the future.

Co-authorship network of co-authors of Meghan Shea

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan Shea. A scholar is included among the top collaborators of Meghan Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan Shea. Meghan Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konstantinopoulos, Panagiotis A., Elizabeth K. Lee, Carolyn Krasner, et al.. (2025). Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer. JCO Precision Oncology. 9(9). e2400882–e2400882.
2.
3.
4.
Jia, Lily, Katharine M. Esselen, Naima T. Joseph, et al.. (2024). Oxaliplatin desensitization for ovarian cancer in pregnancy: A case report. Gynecologic Oncology Reports. 52. 101354–101354.
5.
Konstantinopoulos, Panagiotis A., Mingyang Cai, Niya Xiong, et al.. (2024). Serial circulating tumor DNA (ctDNA) sequencing to monitor response and define acquired resistance to letrozole/abemaciclib in endometrial cancer (EC).. Journal of Clinical Oncology. 42(16_suppl). 5592–5592.
6.
Konstantinopoulos, Panagiotis A., Niya Xiong, Carolyn Krasner, et al.. (2024). Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer. Gynecologic Oncology Reports. 52. 101348–101348. 2 indexed citations
7.
Shea, Meghan, et al.. (2023). Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic. The FASEB Journal. 37(5). e22914–e22914. 4 indexed citations
8.
Seery, Virginia, et al.. (2022). Monitoring Endocrine Complications of Immunotherapy: A Screening Tool. Cureus. 14(7). e26859–e26859. 1 indexed citations
9.
Dechen, Tenzin, et al.. (2021). Implementing Electronic Patient-Reported Outcomes for Patients With New Oral Chemotherapy Prescriptions at an Academic Site and a Community Site. JCO Clinical Cancer Informatics. 5(5). 631–640. 12 indexed citations
10.
Esselen, Katharine M., Annika Gompers, Michele R. Hacker, et al.. (2021). Evaluating meaningful levels of financial toxicity in gynecologic cancers. International Journal of Gynecological Cancer. 31(6). 801–806. 66 indexed citations
11.
Xiong, Niya, Nabihah Tayob, Carolyn Krasner, et al.. (2020). LBA35 Phase II study of PARP inhibitor talazoparib and PD-L1 inhibitor avelumab in patients (pts) with microsatellite stable (MSS) recurrent/persistent endometrial cancer. Annals of Oncology. 31. S1165–S1165. 11 indexed citations
12.
13.
Lin, Douglas I., Amanda Hemmerich, Claire Edgerly, et al.. (2020). Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss. Gynecologic Oncology. 157(2). 357–366. 40 indexed citations
14.
Bouberhan, Sara, Meghan Shea, Alice Kennedy, et al.. (2019). Financial toxicity in gynecologic oncology. Gynecologic Oncology. 154(1). 8–12. 89 indexed citations
15.
Shea, Meghan, et al.. (2018). Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis. Cancer Treatment and Research Communications. 15. 17–20. 11 indexed citations
16.
17.
Bouberhan, Sara, et al.. (2018). Polymyositis as a presentation of advanced carcinoma of Mullerian origin: A case report and discussion. Gynecologic Oncology Reports. 25. 1–2. 2 indexed citations
18.
Leonardi, Giulia C., Anika E. Adeni, Christine Lydon, et al.. (2018). Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(7). 1037–1042. 69 indexed citations
19.
Rangachari, Deepa, Paul A. VanderLaan, Meghan Shea, et al.. (2017). Correlation between Classic Driver Oncogene Mutations in EGFR , ALK , or ROS1 and 22C3–PD-L1 ≥50% Expression in Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(5). 878–883. 104 indexed citations
20.
Shea, Meghan, Mark S. Huberman, & Daniel B. Costa. (2016). Lazarus-Type Response to Crizotinib in a Patient with Poor Performance Status and Advanced MET Exon 14 Skipping Mutation–Positive Lung Adenocarcinoma. Journal of Thoracic Oncology. 11(7). e81–e82. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Giuliani Breakdown of academic impact, for papers by Gül Başaran Breakdown of academic impact, for papers by F Marchesi Breakdown of academic impact, for papers by Chongqing Tan Breakdown of academic impact, for papers by G. Schubert-Fritschle Breakdown of academic impact, for papers by Atara Ntekim Breakdown of academic impact, for papers by Daniele Lisi Breakdown of academic impact, for papers by Laura Marandino Breakdown of academic impact, for papers by Bernardo H. L. Goulart Breakdown of academic impact, for papers by Mihaela Mates
Rankless by CCL
2026